Abstract: About 15 years ago, the steered molecular dynamics (SMD) was used to probe binding of ligand to biomolecule surfaces but in terms of drug design this approach has only recently attached attention of researchers. The main idea of using SMD to screen out leads is based on the hypothesis that the larger is the force needed to unbind a ligand from a receptor the higher its binding affinity. Thus, instead of binding free energy, the rupture force defined as the maximum on the force-time/displacement profile, is used as a score function. In this mini-review, we discuss basic concepts behind the experimental technique atomic force microscopy as well as SMD. Experimental and theoretical works on the application of SMD to the drug design problem are covered. Accumulated evidences show that SMD is as accurate as the molecular mechanics-Poisson-Boltzmann surface area method in predicting ligand binding affinity but the former is computationally much more efficient. The high correlation level between theoretically determined rupture forces and experimental data on binding energies implies that SMD is a promising tool for drug design. Our special attention is drawn to recent studies on inhibitors of influenza viruses.
I. INTRODUCTION
The design of one new drug approved by FDA takes about 15 years at expenses of nearly one billion USD. In order to shorten this process and make it less expensive, computer simulations can be used to identify leads and validate them as potential drugs. Top-leads predicted by computers may be recommended for further clinical trials on toxicity and drug-ability. From the physical point of view, the ligand binding affinity is defined by the binding energy of ligand to receptor. The binding energy can be estimated either by the docking method [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] or molecular dynamics (MD) simulations. The former method is very fast and can be used for screening potential leads from a large number of ligands available in various data bases [21] . However, its predictive power is low due to ignorance of receptor dynamics and a limited number of position trials of ligand.
There are several methods based on MD simulations like linear interaction energy (LIE) [22, 23] , molecular mechanics/Poisson-Boltzmann (Generalized Born) surface area (MM/PB(GB)SA) [24, 25] , free energy perturbation (FEP) [26] or thermodynamic integration (TI) [27] etc. All these methods are more accurate than the structure-based screening as they take into account dynamics of both ligand and receptor but they are not free from drawbacks associated with approximations they adopt. One of their disadvantages is that they are computationally much more expensive than the docking method and can only be used to study a very limited number of targets. Thus it is worth to work out a method which would be accurate enough but computationally less expensive compared to standard MD simulation methods.
Recently, motivated by the atomic force microscopy (AFM) experiments the steered molecular dynamics (SMD) [28, 29] has developed and applied to study mechanical unfolding of biomolecules [30, 31] , transportation of ions [32, 33] and organic compounds through membrane channels [34, 35] . This method is also employed to probe unbinding pathways of ligand from its receptor [36, 37] . In this minireview, we try to demonstrate that SMD is one of possible candidates to achieve two goals of drug design: more accurate than docking and more efficient than MD methods.
Basic concepts of the SMD will be described. Its application to to study ligand binding affinity of various complexes will be covered with focus on recent results obtained for the influenza virus problem. SMD is shown to be as powerful as MM-PBSA method in predicting binding affinity but about one order of magnitude faster.
II. STEERED MOLECULAR DYNAMICS METHOD
Inter-and intra-molecular forces are key to the stability of biomolecules. Up to now understanding of these forces is possible through indirect physical and thermodynamical measurements like crystallography, light scattering, nuclear magnetic resonance spectroscopy etc. In the case of ligand binding to receptor the binding energy E bind is estimated via equilibrium association constant K a constants using the equation E bind = RT ln(K a ). Single molecule force spectroscopy experiments such as AFM [38] , laser optical tweezers [39] and magnetic tweezers [40] can directly probe molecular forces and provide unexpected insights into the strength of forces driving various interactions responsible for the mechanical stability of bio-systems.
In standard single molecule force spectroscopy experiments one terminal (end) of a biomolecule is anchored to a surface, while another terminal is attached to a force sensor. A biomolecule is stretched by increasing the distance between the surface and the force sensor. In the AFM case, the force sensor is a micron-sized cantilever. After the pioneering AFM experiment of Gaub et al. [41] , a lot of experimental as well as theoretical works have been done on proteins, DNA and RNA [42, 43] . Biomolecules are pulled either with a constant force or by a force ramped with a constant loading rate. The force-extension curve of proteins under constant rate pulling has a saw-tooth shape due to domain by domain unfolding [44] . Schulten's group [45] was first to reproduce this remarkable result by SMD simulations.
To probe the binding affinity of ligand to receptor, one applies the external force to pull ligand from the binding pocket without fixing any atom of ligand (Fig. (1a) ). As in the single molecule force spectroscopy the force experienced by ligand is proportional to the displacement of the cantilever. Under the force loaded with a constant rate the total energy of the receptor-ligand complex is as follows
Here E receptor ,E ligand and E receptor-ligand are energies of receptor, ligand and receptor-ligand interaction, respectively. Their forms depend on force fields used to describe the binding process. In AFM experiments, the spring constant of cantilever tip k is about 10 -1000 pN/nm and x is the displacement of atom, which the force is applied to, from its initial position. v is the pulling speed while kv is the force loading rate. The ligand experiences the force F = kx which is measured in experiments.
The breaking of hydrogen bonds (HB) requires a force f H /a. Assuming the hydrogen bond energy H 1kcal/mol and typical distance between two atoms a 0.4 nm one needs force f 10 pN or a pulling rate v 100 nm/s to break a HB within one tenth of second using cantilever with k = 10 pN/nm. Suppose the binding pocket size 1 nm and the experimental pulling rate v 100 nm/s, then one needs time 10 2 s to expose a ligand to the environment. Since within present computational facilities one can run all-atom MD simulations up to 1 s, one has to pull ligand at least 10 4 times faster than in experiments. MD with high pulling speed or large constant force is called SMD. Nowadays, this method is implemented in most of softwares like GROMACS [46] , AMBER [47] , CHARMM [48] and NAMD [49] . Fig. (1b) shows a typical force-displacement profile for pulling ligand from the binding pocket with constant loading rate. Initially, the force experienced by ligand grows almost linearly in accord with the Hooke law. The peak is associated to sharp drop of not only the number of HBs but also the electrostatic and van der Waals (vdW) interactions [50] . The rupture force Fmax which defines the mechanical stability of ligand is directly related to unbinding but not binding process. However, intuitively one can hypothesize that the larger is the force needed to unbind a ligand from a receptor the higher its binding affinity. For comparison with experiments, one can use the following approximation (2) Here is an effective displacement which presumably depends on systems and force fields used to treat them. Thus, in the SMD approach, instead of the binding free energy the rupture force is used as a score function to measure binding affinity. F max cannot be directly compared with the ligand inhibitory capacity but it can be used to obtain relative binding affnities. Considering W = F max x eff as the work performed in transition from bound to unbound state, one can show that Eq. (2) can be obtained in the first approximation in the cumulant expansion of the Jarzynski equality [51, 52] .
Using the Bell-Evans-Ritchie argument [53, 54] one can show that Fmax depends on the pulling speed logarithmically, F max ln(v) [55, 56] . Therefore, to compare binding properties of different complexes SMD simulations should be carried out at the same v. For loading rates of 10 0 -10 5 pN/s, the rupture force varies between 10 0 -10 2 pN [55] .
As follows from studies of mechanical unfolding of proteins, the rupture force is sensitive to pulling direction [42, 57, 58] . Therefore, it is important to establish what pulling path should be chosen. If biomolecule is stretched with one point fixed, the force is directed along the vector connecting the anchored point and the point which the force is applied to. The situation becomes more complicated when a ligand is pulled from the binding site not keeping any atom fixed. In this case, one can not pull along arbitrary direction and an optimal pathway can be chosen [50] using, e.g. Caver 2.0 [59] , a plugin of Pymol. The optimal path goes through the widest tunnel which is directed outside the binding pocket. The corresponding rupture force would be smallest among all possible pathways.
III. APPLICATION OF SMD TO LIGAND BINDING PROBLEM

A. Influenza Virus
Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the influenza viruses), that affects birds and mammals. Among three different classes A, B and C of influenza viruses, only type A has been observed to cause severe disease and pandemic [60] . In the last century, influenza pandemics occurred in 1918 (Spanish, H1N1), 1957 (Asian, H2N2) and 1968 (Hong Kong, H3N2) and killed millions of people [61, 62] . Recently, two types of influenza virus, H5N1 (avian flu) [63, 64] and H1N1 (swine flu) [65] , have occurred and spread all over the world causing death in both people and millions of poultry. For the time being the swine flu H1N1 is in a post-pandemic phase, but no one can predict when the next pandemic will occur.
Influenza viruses A, B and C are very similar in overall structure ( Fig. (2) ). They are made of a viral envelope containing glycoproteins, wrapped around a central core. The central core contains the viral RNA genome and other proteins that package and protect this RNA. The influenza A genome contains 11 genes on eight pieces of RNA, encoding for 11 proteins: hemagglutinin (HA), neuraminidase (NA), M1, M2, NS1, NS2, NP, PA, PB1, PB1-F2 and PB2 [66] .
A lipid envelop of the viral particle contains the two large glycoproteins HA and NA and the transmembrane protein M2. HA is a lectin that mediates binding of the virus to target cells and entry of the viral genome into the target cell, while NA plays a critical role in the release of progeny virus from infected cells by cleaving sugars that bind the mature viral particles [67, 68] . The integral membrane protein M2 is associated with the proton channel blocking of which can prevent the virus from being able to uncoat. Thus, HA, NA and M2 are targets for antiviral drugs [69] [70] [71] . Influenza A viruses are classified into subtypes based on antibody responses to HA and NA. There are 16 HA (H1-H16) and 9 NA (N1-N9) subtypes known [72] , but only H1, H2 and H3, and N1 and N2 are commonly found in humans. A combination of these HA and NA subtypes is used to classify different strains such as H2N2, H5N1, H1N1 etc.
Currently, two types of drugs are licensed to treat influenza virus. The first class is a M2 inhibitor (amantadine and rimantadine) [73] , which blocks the M2 proton channel of influenza virus [74] . These drugs are ineffective against influenza B [74, 75] and a number of amantadine-resistant cases have been reported [76] . The second class of drugs involves the NA inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza), which are able to block the release of new virons from an infected cell [77] . These inhibitors are often effective against both influenza A and B virus [75] , but some strains of avian H5N1 [78, 79] and swine pandemic H1N1 (pH1N1) influenza [80] [81] [82] are resistant to Tamiflu. Thus, it is vital to design a drug that is capable of treating both wild type (WT) influenza viruses as well as their mutants. In this mini-review, we focus on the application of SMD to study NA inhibitors of H5N1 and pH1N1. Recent results obtained for HA and M2 inhibitors may be found in the review of Rungrotmongkol et al [71] .
Binding Site of NA of H5N1 and pH1N1
NA predominantly exists as a tetramer one chain of which is shown in Fig. (1) . For H5N1 NA the 150-cavity, formed by open conformation of the 150-loop (residues 147-152), is adjacent to the sialic acid binding pocket (Fig. (3) ) [83] . However, this cavity was not found in the pH1N1 NA [84] . The highly conserved binding pocket of H5N1 NA consists of 11 residues R118, E119 D151, R152, R224, H274, E276, R292, N294, Y347, and R371 (Fig. (3) ). The active side of pH1N1 NA differs from H5N1 by only one residue at position 347 where Y347 is replaced by N347.
Nature of Ligand Binding to NA
Conventional MD simulations have been utilized to reveal key factors governing the binding affinity of inhibitors Oseltamivir, Zanamivir and Peramivir to WT and mutants (Y252H, N294S, and H274Y) of H5N1 and pH1N1 [71] . Their binding to H5N1, for instance, is mainly due to hydrogen bonding between the -COO group with the three conserved arginines, R118, R292 and R371, as well as Y347.
Using the SMD method, one can show that the electrostatic interaction between ligand and receptor dominates over the van der Waals one [50, 85] . The hydrogen bonds alone do not define mechanical stability of ligand as they exist after passing the peak in the forcedisplacement profile [50, 86] . Thus, long range interactions also play the important role. Unbinding of tamiflu from the active site of WT H5N1 requires higher Fmax compared to pH1N1 case [50] or the Oseltamivir-pH1N1 NA complex is less stable than the H5N1 NA one. This is in accord with other theoretical works, where the binding free energies have been estimated using different force fields and methods [87] [88] [89] . The difference in binding affinities of Oseltavimir to pH1N1 and H5N1 lies in different residues at position 347.
After the equilibration step of MD simulation, contrary to the H5N1 case, residue N347 in the active site of pH1N1 moves outward the binding site making its interaction with tamiflu weaker [50] . This assumption was confirmed by SMD simulations showing reduction of the number of HBs between the ligand and the receptor. A detailed geometrical picture on mechanical stability may be obtained monitoring time dependencies of distances between donors and acceptors of ligand and receptor [50] . Within the Gromos force field 43a1, the unbinding of Oseltamivir from pH1N1, for instance, is associated with breaking contacts between its and residues D151, E119, E227, and E277 of NA. It should be noted that the binding as well as unbinding process depend on force fields we use for simulations [90] .
Recent Progress on Development of New NA Inhibitors
The tamiphosphor, the phosphonate congener of Oseltamivir and its analogs show more inhibitory potency than Osltamivir against the H1N1 and H5N1 [58] . This is because the replacement of the COO group by the -PO 3 2 leads to more effective interactions with surrounding residues R118, Y347 and Y406 [91, 92] . Having used the open N1 conformation with the 150-cavity and 430-cavity adjacent to the sialic acid binding site [83] it has been suggested [93] [50] which reveals that four ligands NSC-141562, NSC-5069, NSC-46080 and NSC-117079 ( Fig. (4) ) may be more potent than existing commercial drugs to cope the swine flu. Other potential leads have also been identified [95] [96] [97] [98] . In the search for a more potent anti-H5N1 inhibitor, one should bear in mind that ligands may in general bind to both "open" and "close" conformations of NA. But new leads presumably bind to the "open" conformation better than the "close" one as the latter is known from PDB for Tamiflu. In fact, it has been shown that the open form of crystal structure of NA is a reliable structural basis for designing derivatives of Oseltamivir as new potent drugs [98] .
Experimentally Yamashita et al and other groups disclosed [99] [100] [101] [102] [103] that R-125489 and its prodrug CS-8958 (Fig. (4) ) are promising drugs for treating both influenza A and B as well as their mutants. In an acidic environment, the long tail of CS-8958 is reduced as an ester group is replaced by a hydroxyl group or an acceptor group is transformed into the donor group. Using the density function theory, one can show that in this situation, the free energy of binding of R-125489 is lower than that of CS-8958 [86] . Consequently, CS-8958 easily adopts its active form in R-125489 with much higher binding affinity. In other words, the change in CS-8958 conformation reduces the steric effect and hydroxyl group can interact with polar residues in the active site leading to an increase in the binding affinity of R-125489 to all NAs. We note that intranasally administrated CS-8958 is quickly metabolized to R-125489 in the lungs and can be retained as a metabolite for a long time [99] (remember that intranasally administrated R-125489 is quickly removed from lung). This makes it possible for R-125489 to be used as a long-acting drug.
SMD is a Promising Tool for Drug Design
In studies on the unique beta-hydroxyacyl-ACP dehydratase of Plasmodium falciparum (PfFabZ) [104] and influenza virus [50] , the good correlation between Fmax and experimental free energies was obtained only for 5-6 systems. In recent experiments [99] [100] [101] [102] [103] , the binding affinity of R-125489 and CS-8958 (Fig. (4) ) to 24 receptors (WT and mutants of H5N1, pH1N1, H3N8, H11N9, H8N4, H3N2, H11N6 and virus B) has been probed. In order to check the validity of SMD, the theoretical study of theses systems have been performed by Mai and Li [86] . In agreement with the experiments [99] [100] [101] [102] [103] , R-125489 displays higher binding affinity than CS-8958 (Fig. (5) ). The reason behind this difference lies in the repulsion between the long "tail" with 7 aliphatic carbons of CS-8958 and polar residues of receptor [86] . The excellent correlation between SMD and experiments (R = 0.97), obtained for the sufficiently large data set of 24 systems (Fig. 5) , strongly supports SMD as a very promising for drug design.
B. Other Systems
In the pioneer paper of Grubmuller, Heymann and Tavan [28] , the force required to disassociate the streptavidin-biotin complex was calculated by SMD and the reasonable agreement with the AFM experiments [41] was obtained. The mechanical unbinding pathway of biotin (vitamin B 7 , vitamin H) involves five major unbinding steps suggesting the importance of not only the HB network between receptor and ligand but also additional water bridges. Unbinding of retinoic acid from its receptor follows only one pathway and an alternative "forward door" pathway for binding [105] . The unbinding process of biovitin from avidin which is a tetrameric biotin-binding protein produced in the oviducts of birds, reptiles and amphibians deposited in the whites of their eggs, was also studied in detail [45] . The diversity of unbinding pathways has been observed. The SMD simulations were utilized for investigation of the unbinding of retinal from bacteriorhodophin [106] and the release of phosphate from the back door of actin [107, 108] .
The entering and leaving processes of Huperzine A (HupA) binding with the long active-site gorge of Torpedo californica acetylcholinesterase (TcAChE) have been investigated [36] . SMD was also applied to study unbinding process of E2020 ((R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]-methylpiperidine) from the same receptor TcAChE [109] . Nanosecond scale simulations with different pulling velocities revealed that contrary to inhibitor HupA that undergoes the greatest barrier located at the bottleneck of the gorge, the major resistance preventing E2020 from leaving the gorge is from the peripheral anionic site, where E2020 interacts intensively with several aromatic residues through its benzene ring. This results in a strong direct hydrogen bond and a water bridge with Ser286 via its O24 causing the large rupture force 550 pN [109] . The binding affinity of non-nucleoside inhibitor -APA to human immunodeficiency virus type one reverse transcriptase (HIV-1 RT) has been also probed [110] .
SMD was used to explore the process of Ca 2+ dissociation from the EF-hand motifs of the C-terminal lobe of calmodulin [111] . Based on an analysis of the pulling forces, the dissociation sequences and the structural changes, one can show that the Ca 2+ -coordinating residues lose their binding to Ca 2+ in a stepwise fashion.
The pulling simulations have been carried out to study the possible dissociation pathways of typical type II inhibitor imatinib from its targeting protein kinases c-Kit and Abl [112] . The most favorable pathway for imatinib dissociation corresponds to the ATP-channel rather than the relatively wider allosteric-pocket-channel, which is mainly due to the different van der Waals interaction that the ligand suffers during dissociation. The pathway for glutamine to release from glutamine-binding proteins was revealed by SMD simulations [113] .
Plasmodium falciparum mamalia infections are estimated to be about half a billion annually continuing to threaten lives in tropical and subtropical zones of the world [114] . The unique beta-hydroxyacyl-ACP dehydratase of Plasmodium falciparum was shown to be a target for antimalarial drug design. Combining the docking with single-molecule pulling simulations Colizzi et al. [104] have studied the binding affinity of six monohydroxylated flavones to PfFabZ. In agreement with the experiments [104] SMD-derived force profiles have shown to discern active from inactive compounds.
The estrogen receptors (ERs) belong to a superfamily named nuclear receptors, which play crucial roles in the human body, including the growth and differentiation of the reproductive system, the central nervous system, and the skeletal system. ERs have two subtypes, ER and ER . Ligands such as WAY-244 and Genistein exert their regulatory effects via binding ERs, which induces conformational changes in the protein structure and produces the physiological effects of the receptor. Unbinding pathways of these ligands have been probed by SMD [115] indicating that His524/475 in ER /ER acted as a "gatekeeper" during the unbinding process.
SMD simulations of ligand-receptor interaction in lipocalins have been performed [116] . The difference in binding mechanism of retinol to its binding protein (RBP) and digoxigenin to an engineered lipocalin, DigA16, have been studied in detail using 10-20 ns simulations. Digoxigenin is bound deep inside the cavity of DigA16 and forms several stable hydrogen bonds in addition to the hydrophobic van der Waals interaction with the aromatic side-chains, while the strongly hydrophobic receptor site of RBP differs considerably from DigA16. Here, the main source of ligand attraction comes from the phenyl sidechains.
Dipeptidyl peptidase IV is an important target for the treatment of Type II diabetes mellitus as it is responsible for the secretion of insulin after dietary intake. Its crystal structure [117] suggests that there are two possible pathways to the active site, a side opening and a beta propeller opening. The pulling simulations have been carried to explore release of inhibitor Q448 from the active site [118] . The comparisons of results, obtained for force-profile, mechanical work and potentials of mean force suggest that the side opening is more favorable for the inhibitor to pass through.
IV. COMPARISON OF SMD WITH OTHER METHODS
The results obtained for G bind depend not only on force fields but also on methods [90, 119] . This is because different approaches adopt different approximations. In LIE method, for instance, the binding free energy is calculated using the interaction energy between ligand and its surroundings in bound and unbound state. However, in most cases, one needs to know a priori binding affinities from experiments and the success of this method crucially depends on empirical parameters. A more accurate estimation of binding energy can be obtained by the FEP/TI method but it is very CPU time consuming.
The comparison of SMD with the MM-PBSA method has been carried out studying the binding affinity of seven ligands (Tamiflu, Relenza, Peramivir, and four ligands 141562, 5069, 46080 and 117079 from the NSC) to pH1N1 NA [50] . Since, the correlation between G bind and F max for these compounds is very high (R = 0.95), SMD is expected to be as good as MM/PBSA in drug design. Nevertheless, to cement this conclusion, one has to have better statistics than just seven systems. The advantage of SMD is that it is about 30-fold faster than MM-PBSA if we choose the pulling speed v = 0.005 mn/ps [50] . Thus, the number of ligands that may be studied by this method is about one order of magnitude larger than other MD methods. Even though, SMD method cannot be used to screen leads from large ligand data bases as the docking technique [21] . Another disadvantage of SMD is that it can predict relative binding affinities but not the absolute ones as in other MD approaches. One should bear in mind also some drawbacks of these methods. For instance, MM-PBSA is quite good in ranking binding affinity but its performance is relatively poor in some cases [120, 121] . This is due to the approximation in which the explicit solvent is represented as a continuum having a relatively high dielectric constant, while the protein and ligand are viewed as point charges projected onto a grid in a low dielectric constant.
V. CONCLUSION
The problem of calculating the potential of mean force (the free energy along a reaction coordinate) by combination of SMD with Jarzynski's equality [52, 122] and weighted histogram analysis [123, 124] has not been discussed. This is partially because in terms of binding affinity the potential of mean force does not provide much more insight compared to the rupture force. We have reviewed results obtained by the SMD where the ligand is pulled along one direction. Recently, a modified method with adjusting pulling direction to search an optimum trajectory of ligand dissociation has been proposed [125, 126] . The pathway obtained by this method has less dissociation time, smaller rupture force and lower energy barrier than that by the conventional SMD. The so called hybrid SMD-docking method [127] that uses the score different from G bind and F max also looks promising.
The complete reconstruction of an enzyme-inhibitor binding process by standard molecular dynamics simulations is computationally very expensive. For instance, to get reasonable description of benzamidine binding to trypsin one has to perform 495 molecular dynamics simulations of free ligand binding of 100 ns each, 187 of which produced binding events [128] . Therefore, new ideas for further improvement of SMD would be highly desirable for drug design.
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